drugset / Trial / NCT04941313
Phase 1 Study of 3D229 in Healthy Subjects
RandomizedParallel-groupSingle-blindTreatment
Summary
This is a Phase 1 Study to Evaluate the Safety and tolerability of 3D-229 in health subjects
Timeline
- Start
- 2021-07-27
- Primary completion
- 2021-11-15
- Completion
- 2022-02-21
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | 3D229 | Unknown | — | Intravenous |
Indications
No indication recorded.